Long‐term exposure to dietary sources of genistein induces estrogen‐independence in the human breast cancer (MCF‐7) xenograft model

SCOPE: The long‐term effect of exposure to relevant dietary levels of genistein (GEN) on estrogen receptor‐positive (ER+) human breast cancer (MCF‐7) progression after GEN withdrawal in athymic mice xenograft model was studied. MATERIALS AND METHODS: Feeding studies were conducted to determine the e...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecular nutrition & food research 2015-03, Vol.59 (3), p.413-423
Hauptverfasser: Andrade, Juan E, Ju, Young H, Baker, Chandra, Doerge, Daniel R, Helferich, William G
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:SCOPE: The long‐term effect of exposure to relevant dietary levels of genistein (GEN) on estrogen receptor‐positive (ER+) human breast cancer (MCF‐7) progression after GEN withdrawal in athymic mice xenograft model was studied. MATERIALS AND METHODS: Feeding studies were conducted to determine the estrogenic effect of diets on MCF‐7 tumor growth: (1) implantation (19 weeks) and withdrawal (6 weeks) of 17β‐estradiol (E₂); (2) dietary GEN 500 and 750 ppm during treatment/withdrawal for 23/10 and 15/9 weeks, respectively; and, (3) dietary soy protein isolate (SPI) containing GEN 180 ppm for 31/9 weeks of treatment/withdrawal. MCF‐7 tumors grew fast in the presence of E₂implantation and abruptly regressed completely after E₂withdrawal. At different rates, dietary GEN alone (500 and 750 ppm) and GEN (180 ppm)‐containing SPI stimulated MCF‐7 tumor growth. After removal of the stimulus diet, tumors induced by 750 ppm GEN, but not 500 ppm GEN or SPI, regressed completely. The protein expression of epidermal growth factor receptor 2 (HER2) was higher in the GEN‐ and SPI‐induced nonregressing (GINR) tumors compared to MCF‐7 and E₂controls. CONCLUSION: Long‐term consumption of low GEN doses (≤500 ppm) promotes MCF‐7 tumor growth and results in GINR tumors with more aggressive and advanced growth phenotypes.
ISSN:1613-4125
1613-4133
DOI:10.1002/mnfr.201300780